Zoetis Inc header image

Zoetis Inc

ZTS

Equity

ISIN null / Valor 19276994

New York Stock Exchange, Inc (2026-09-08)
USD 73.56-2.97%

Zoetis Inc
UMushroom community rating:

star star star star star
3.57 5 votes No rating yet
NegativeNeutralPositive

About company

Zoetis Inc. is a global leader in the animal health industry, providing a comprehensive range of products and services that cater to the health needs of animals. With operations spanning over 100 countries, the company's portfolio encompasses a wide array of medicines, vaccines, diagnostics, and technologies designed to support the health and well-being of animals across various sectors, including livestock and companion animals. Zoetis is recognized for its innovative approach in developing solutions that address both common and emerging health challenges faced by animals, thereby contributing significantly to the global animal health sector. The company's commitment to research and development is evident in its robust pipeline, which ensures a continuous introduction of new and improved products to the market, further solidifying its position as a key player in the animal health industry.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-51.5%1Y
-60.4%3Y
-64.9%5Y

Performance

39.7%1Y
31.2%3Y
30.1%5Y

Volatility

Market cap

30397 M

Market cap (USD)

Daily traded volume (Shares)

5,658,696

Daily traded volume (Shares)

1 day high/low

163.89 / 161.59

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.57

5 votes
Performance:
starstarstarstarstar
3.71
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
4.00
Noah Juganar
UK, 23 Oct 2025
star star star star star
Solid fundamentals in financials & competitive advantages
D X
Switzerland, 16 Apr 2025
star star star star star
Langfristige Chance
D X
Switzerland, 29 Mar 2025
star star star star star
Ein Unternehmen, das meiner Meinung nach in einem zukunftsträchtigen Markt vorne mit dabei ist.

EQUITIES OF THE SAME SECTOR

Attendo AB
Attendo AB Attendo AB Valor: 30491576
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.41%SEK 122.00
aap Implantate AG
aap Implantate AG aap Implantate AG Valor: 57872565
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 1.75
Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co. KGaA Draegerwerk AG & Co. KGaA Valor: 330446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%EUR 110.20
Unitedhealth Group Inc
Unitedhealth Group Inc Unitedhealth Group Inc Valor: 1078451
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.93%USD 400.84
COLTENE HOLDING AG
COLTENE HOLDING AG COLTENE HOLDING AG Valor: 2534325
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.64%CHF 46.90
AbbVie Inc
AbbVie Inc AbbVie Inc Valor: 20145667
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.99%USD 248.78
Pfizer Inc
Pfizer Inc Pfizer Inc Valor: 962004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.32%USD 27.79
DocMorris Ltd
DocMorris Ltd DocMorris Ltd Valor: 4261528
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.69%CHF 10.04
Abbott Laboratories
Abbott Laboratories Abbott Laboratories Valor: 903037
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.59%USD 105.52
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1103058
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.57%GBP 10.26